US Patent No: 8,012,990

Number of patents in Portfolio can not be more than 2000

Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia

Stats

ALSO PUBLISHED AS: 20110086874
ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

A method of converting a treatment for pain comprising intravenous administration of opioids, to a treatment for pain comprising oral administration of a first dose of an immediate release morphine-oxycodone combination in patients in need of analgesia. The method may comprise (1) determining a four-hour average oral morphine equivalents or determining a net average hourly intravenous dose, and (2) orally administering to the patient a first dose of a morphine-oxycodone combination in a 3:2 ratio by weight every four to six hours. Also, a method of treating pain in patients who had been administered opioids intravenously, comprising using a dosing algorithm to determine the first dose of the immediate release morphine-oxycodone combination.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
QRXPHARMA LTD.BEDMINSTER, NJ, AU5

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mengle-Gaw, Laurel J - 6 0
Richards, Patricia T - 7 0
Schwartz, Benjamin D - 3 0
Stern, Warren C Gainesville, FL 13 146

Cited Art

Patent Info (Count) # Cites Year
 
QRXPHARMA LTD. (2)
2005/0053,659 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness 4 2003
2009/0291,975 DUAL OPIOID PAIN THERAPY 5 2009
 
RELEVARE AUST. PTY LTD (1)
2008/0039,463 Methods and Compositions 5 2004
 
The Lynx Project Limited (1)
6,310,072 Production of analgesic synergy by co-administration of sub-analgesic doses of a MU opioid agonist and a kappa-2 opioid agonist 25 1997

Patent Citation Ranking

Forward Cites

  • No Forward Cites to Display

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 6, 2015
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 6, 2019
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 6, 2023
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00